<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent case-control studies reported an association between H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to compare <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, neuroinflammation, and cerebrovascular lesion load in a group of AD patients according to their H. pylori status </plain></SENT>
<SENT sid="2" pm="."><plain>For the 53 AD patients included, we assessed: clinical data (vascular comorbidities and cognitive assessment), biological data (especially fibrinogen, <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E4 genotype; cerebrospinal fluid [CSF] total tau protein [Tau], phospho-tau(181) protein [pTau(181)]), and amyloid beta <z:chebi fb="7" ids="16670">peptide</z:chebi> levels, serum/CSF-cytokines (interleukin [IL]-1β, IL-6, IL-8, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor [TNF]-α) and pepsinogen I/pepsinogen II (PgI/PgII) ratio, and cerebrovascular lesion load (magnetic resonance imaging [MRI] fluid-attenuated inversion recovery [FLAIR] with the Fazekas and <z:e sem="disease" ids="C0085860" disease_type="Disease or Syndrome" abbrv="">Schmidt</z:e> scale) </plain></SENT>
<SENT sid="3" pm="."><plain>H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was diagnosed by enzyme-linked immunosorbent assay (ELISA) and immunoblot test </plain></SENT>
<SENT sid="4" pm="."><plain>H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was associated with a decreased Mini Mental State Examination (<z:chebi fb="1" ids="25255">MMS</z:chebi>) (p = 0.024), and higher CSF pTau(181) (p = 0.014) and tau (p = 0.021) levels </plain></SENT>
<SENT sid="5" pm="."><plain>A decreased PgI/II ratio (i.e., an increased gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath>) was associated with the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (p = 0.005) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> levels were positively correlated to Fazekas score (r = 0.34; p = 0.032) and to H. pylori immunoglobulin (Ig)G levels (r = 0.44; p = 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Higher CSF cytokine levels (IL-8, p = 0.003; TNF-α, p = 0.019) were associated with the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, but systemic <z:mp ids='MP_0001845'>inflammation</z:mp> results were controversial </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, in multivariate analysis, a lower MMSE score (odds ratio [OR], 0.83 [0.72-0.97]; p = 0.017), plasma IL-1β level (OR, 0.31 [0.11-0.87]; p = 0.025), an increased gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath>, i.e., a lower PgI/PgII ratio (OR, 0.63 [0.43-0.93]; p = 0.020) were still associated with the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>AD patients infected by H. pylori tended to be more cognitively impaired </plain></SENT>
<SENT sid="10" pm="."><plain>Studies are needed to attest to the impact of H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> on AD course, especially on cerebrovascular lesions and neuroinflammation </plain></SENT>
</text></document>